Patents by Inventor Eresha Mendis

Eresha Mendis has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 7855188
    Abstract: The present invention relates to the quaternized amino glucosamine, it can exert an anticancer effect via induction of apoptosis in a dose and time dependant manner through which an anticancer treatment effect can be increased.
    Type: Grant
    Filed: September 14, 2006
    Date of Patent: December 21, 2010
    Assignee: Pukyong National University Industry-Academic Cooperation Foundation
    Inventors: Moon-Moo Kim, Se-Kwon Kim, Eresha Mendis
  • Publication number: 20090240046
    Abstract: The present invention relates to the CGlc compound for inhibiting the expression and activation of MMP-9 in HT1080 and the MMP-9 inhibitor comprising the CGlc compound as an effective ingredient, which can inhibits the expression of AP-1 in Ht1080 to effectively inhibit the expression and activation of MMP-9 such that it is effectuated in treating a wound, metastasis, rheumatoid arthritis, inflammation, hyperparathyroidism, diabetes, cornel ulcer, osteoporosis, stomach ulcer, trauma, pimple, burn, periodontal disease, arteriosclerosis or fracture.
    Type: Application
    Filed: September 14, 2006
    Publication date: September 24, 2009
    Inventors: Moon-Moo Kim, Se-Kwon Kim, Eresha Mendis
  • Publication number: 20090176978
    Abstract: The present invention relates to the quarternized amino glucosamine, it can exert an anticancer effect via induction of apoptosis in a dose and time dependant manner through which an anticancer treatment effect can be increased.
    Type: Application
    Filed: September 14, 2006
    Publication date: July 9, 2009
    Applicant: Pukyong National University Industry-Academic Cooperation Foundation
    Inventors: Moon-Moo Kim, Se-Kwon Kim, Eresha Mendis